Interleukin 10-2849AA genotype protects against pre-eclampsia

Genes and Immunity

Volumn 5, Issue 4, 2004, Pages 313-314

  de Groot, C J M ^a   Jansen, M W J C ^a   Bertina, R M ^b   Schonkeren, J J M ^b   Helmerhorst, F M ^b   Huizinga, T W J ^b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Interleukin 10; Pathofysiology; Pre eclampsia; Pregnancy

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC MARKER; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HIGH RISK PREGNANCY; HOMOZYGOSITY; HUMAN; HYPOTHESIS; IMMUNITY; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT;

CASE-CONTROL STUDIES; FEMALE; GENOTYPE; HOMOZYGOTE; HUMANS; INTERLEUKIN-10; POLYMORPHISM, GENETIC; PRE-ECLAMPSIA; PREGNANCY; PROMOTER REGIONS (GENETICS);

TRIXIS;

EID: 3242739291     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6364092     Document Type: Article

References (14)

1. Westendorp RG, Langermans JA, Huizinga TW et al. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 18: 170-173.
2. Westendorp RG, van Dunne FM, Kirkwood TB, Helmerhorst FM, Huizinga TW. Optimizing human fertility and survival. Nat Med 2001; 7: 873.
3. de Jong B, Westendorp RGJ, Eskdale J, UitdeHaag BML, Huizinga TWJ. Frequency of functional interleukin-10 promoter polymorphism is different between relapse-onset and primary progressive multiple sclerosis. Hum Immunol 2002; 63: 281-285.
4. Erlebacher A. Why isn't the fetus rejected? Curr Opin Immnunol 2001; 13: 590-593.
5. Roberts JM, Cooper DW. Pathogenesis and genetics of pre-eclampsia. Lancet 2001; 357: 53-56.
6. Wilson ML, Goodwin TM, Pan VL, Ingles SA. Molecular epidemiology of preeclampsia. Obstet Gynecol Surv 2003; 58: 39-66.
7. de Groot C, Bloemenkamp KW, Duvekot EJ, Helmerhorst FM, Bertina RM, Van Der Meer F, De Ronde H, Oei SG, Kanhai HH, Rosendaal FR. Preeclampsia and genetic risk factors for thrombosis: a case-control study. Am J Obstet Gynecol 1999; 181: 975-980.
8. Gibson AW, Edberg JC, Wu J, Westendorp RGJ, Huizinga TWJ, Kimberly RP. Novel single nucleotide polymorphisms in the distal IL10 promoter affect IL10 production and enhance the risk of SLE. J Immunol 2001; 166: 3915-3922.
9. Westendorp RGJ, Langermans JAM, Huizinga TWJ, Eloudi AH, Verweij CL, Vandenbroucke JP. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997; 349: 170-173.
10. Jong BA, Westendorp RGJ, Eskdale J, Uitdehaag BMJ, Huizinga TWJ. Frequency of functional IL10 polymorphism is different between relapse-onset and primary progressive MS. Hum Immunol 2002; 63: 281-285.
11. Roth I, Fisher SJ. IL-10 is an autocrine inhibitor of human placental cytotrophoblast MMP-9 production and invasion. Dev Biol 1999; 205: 194-204.
12. Hennessy A, Pilmore HL, Simmons LA, Painter DM. A deficiency of placental IL-10 in preeclampsia. J Immunol 1999; 163: 3491-3495.
13. Marjono B, Tong S, Wallace E. Inconsistent detection of interleukin-10 in the maternal serum. BJOG 2002; 109: 1426-1427.
14. Djurovic S, Clausen T, Wergeland R, Brosstad F, Berg K, Henriksen T. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre-eclampsia. BJOG 2002; 109: 759-764.